Literature DB >> 19548048

Multicenter investigation comparing a highly efficient half-time stress-only attenuation correction approach against standard rest-stress Tc-99m SPECT imaging.

Timothy M Bateman1, Gary V Heller, A Iain McGhie, Staci A Courter, Robert A Golub, James A Case, S James Cullom.   

Abstract

BACKGROUND: New iterative algorithms for scatter compensation (SC), noise suppression, and depth-dependent collimator resolution (RR) can shorten rest and stress SPECT acquisitions by 50% while maintaining quality and accuracy equivalent to conventional scans. Full-time stress-only myocardial perfusion SPECT is accurate and efficient when combined with line-source attenuation correction (LSAC). We investigated the potential for half-time stress-only LSAC-SPECT by comparing this to conventional rest/stress SPECT in patients imaged for suspected CAD at three different centers.
METHODS: One hundred and ten patients (58% men, 53% exercise) had 64 projection rest/stress Tc-99m ECG-gated SPECT with simultaneous Gd-153 LSAC: 18 had <or=5% CAD likelihood and 92 had coronary angiography. The stress scans were retrospectively 'stripped' to create equally spaced 32 projection "half-time" (HT) scans for the emission and transmission (TX) projections. Astonish (Philips, Milpitas, CA) processing with AC, SC, and RR was applied to the HT data with the HT TX maps reconstructed using a Bayesian iterative method. The conventional rest/stress image sets processed using filtered back projection and without AC and the HT-AC stress-only images were interpreted in random sequence by consensus of two readers blinded to clinical information in separate reading sessions.
RESULTS: Comparing rest/stress FBP and HT-LSAC, stress perfusion quality was excellent/good in 82 and 89% (P = .13); interpretive certainty (definitely normal or abnormal) was 88 and 95% (P = .14); sensitivity was 77 and 83% (P = .38); specificity was 67 and 71% (P = .65); normalcy was 94 and 100% (P = 1.0); SSS for CAD pts was 7.4 vs 7.8 and for non-CAD pts was 0.7 vs 0 (P = .44 and .16, respectively). Mean stress LVEF was 60% in both groups.
CONCLUSION: Stress-only imaging with HT-LSAC using the Astonish acquisition/processing method provides results equivalent to conventional rest/stress scanning. This new approach has the potential to significantly improve operational efficiency without sacrificing accuracy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548048     DOI: 10.1007/s12350-009-9109-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  16 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Combined analysis of resting regional wall thickening and stress perfusion with electrocardiographic-gated technetium 99m-labeled sestamibi single-photon emission computed tomography: prediction of stress defect reversibility.

Authors:  H J Snapper; N L Shea; M A Konstam; E Oates; J E Udelson
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

3.  Instrumentation quality assurance and performance.

Authors:  Kenneth J Nichols; Stephen L Bacharach; Steven R Bergmann; S James Cullom; Edward P Ficaro; James R Galt; Gary V Heller; Jonathan Links; Josef Machac
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

4.  Clinical results of a novel wide beam reconstruction method for shortening scan time of Tc-99m cardiac SPECT perfusion studies.

Authors:  Salvador Borges-Neto; Robert A Pagnanelli; Linda K Shaw; Emily Honeycutt; Shuli C Shwartz; George L Adams; Ralph Edward Coleman
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

5.  Recent technologic advances in nuclear cardiology.

Authors:  James A Patton; Piotr J Slomka; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

6.  Issues regarding radiation dosage of cardiac nuclear and radiography procedures.

Authors:  Randall C Thompson; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

7.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

8.  Low event rate for stress-only perfusion imaging in patients evaluated for chest pain.

Authors:  Peter B Gibson; Diane Demus; Richard Noto; William Hudson; Lynne L Johnson
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

9.  Gated stress-only 99mTc myocardial perfusion SPECT imaging accurately assesses coronary artery disease.

Authors:  C A Santana; E V Garcia; J P Vansant; E G Krawczynska; R D Folks; C D Cooke; T L Faber
Journal:  Nucl Med Commun       Date:  2003-03       Impact factor: 1.690

10.  A Bayesian iterative transmission gradient reconstruction algorithm for cardiac SPECT attenuation correction.

Authors:  James A Case; Bai Ling Hsu; Timothy M Bateman; S James Cullom
Journal:  J Nucl Cardiol       Date:  2007-04-27       Impact factor: 5.952

View more
  36 in total

1.  Stress-only imaging in patients with prior SPECT MPI: a simulation study.

Authors:  John J Ryan; Rupa Mehta; Thejasvi Thiruvoipati; R Parker Ward; Kim Allan Williams
Journal:  J Nucl Cardiol       Date:  2012-01-19       Impact factor: 5.952

2.  Patient-centered imaging.

Authors:  E Gordon Depuey; John J Mahmarian; Todd D Miller; Andrew J Einstein; Christopher L Hansen; Thomas A Holly; Edward J Miller; Donna M Polk; L Samuel Wann
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

3.  Advances in SPECT camera software and hardware: currently available and new on the horizon.

Authors:  E Gordon DePuey
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

4.  Recommendations for reducing radiation exposure in myocardial perfusion imaging.

Authors:  Manuel D Cerqueira; Kevin C Allman; Edward P Ficaro; Christopher L Hansen; Kenneth J Nichols; Randall C Thompson; William A Van Decker; Marko Yakovlevitch
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

5.  Wide-beam reconstruction half-time SPECT improves diagnostic certainty and preserves normalcy and accuracy: a quantitative perfusion analysis.

Authors:  Regina S Druz; Lawrence M Phillips; Michelle Chugkowski; Loukas Boutis; Bruce Rutkin; Stanley Katz
Journal:  J Nucl Cardiol       Date:  2010-12-23       Impact factor: 5.952

Review 6.  Advances in technical aspects of myocardial perfusion SPECT imaging.

Authors:  Piotr J Slomka; James A Patton; Daniel S Berman; Guido Germano
Journal:  J Nucl Cardiol       Date:  2009-02-26       Impact factor: 5.952

Review 7.  Recent advances in cardiac SPECT instrumentation and system design.

Authors:  Mark F Smith
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

8.  Comparison of attenuation, dual-energy-window, and model-based scatter correction of low-count SPECT to 82Rb PET/CT quantified myocardial perfusion scores.

Authors:  R Glenn Wells; Karen Soueidan; Rachel Timmins; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2013-06-05       Impact factor: 5.952

9.  Nuclear cardiology in the present and beyond: can we meet the challenges?

Authors:  Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-05-25       Impact factor: 5.952

10.  Drivers of radiation dose reduction with myocardial perfusion imaging: A large health system experience.

Authors:  Firas J Al Badarin; John A Spertus; Timothy M Bateman; Krishna K Patel; Eric V Burgett; Kevin F Kennedy; Randall C Thompson
Journal:  J Nucl Cardiol       Date:  2019-01-31       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.